GO:0140459 response to Gram-positive bacterium: Innate Immune Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140459 response to Gram-positive bacterium describes any process that results in a change in state or activity of a cell or organism as a result of a stimulus from a Gram-positive bacterium.
• The response is triggered by conserved Gram-positive cell envelope molecules such as lipoteichoic acid (LTA) and peptidoglycan, which are sensed by innate immune receptors.
• Macrophages are central effector cells in this response, and forward genetic screens have identified novel innate immune genes that specifically regulate the macrophage response to Gram-positive bacteria.
• Gram-positive bacteria use quorum sensing and competence regulons as general stress responses, which shapes how the host detects and responds to them.
• Clinically, dysregulated responses to Gram-positive bacteria underlie osteomyelitis, anthrax pathogenesis, and modulation of anticancer immunity by the intestinal microbiota.
• CRISPR knockout, knock-in, point-mutation, overexpression and library screening enable causal dissection of GO:0140459-related genes in human cell models.
Description
GO:0140459 response to Gram-positive bacterium is a Gene Ontology biological process term that captures the full set of cellular and organismal changes triggered by exposure to Gram-positive bacteria. Gram-positive bacteria are distinguished by a thick peptidoglycan cell wall and abundant lipoteichoic acid (LTA), and these conserved envelope molecules are potent innate immune stimuli. The term therefore sits at the intersection of microbiology, immunology and host-pathogen interaction research, and it is used to annotate genes whose expression or activity changes when a cell encounters a Gram-positive organism. Understanding this response matters because it determines whether the host clears the infection or suffers immunopathology. For example, Staphylococcus aureus osteomyelitis is a devastating bone infection in which the host response to a Gram-positive pathogen drives tissue destruction and chronicity. Similarly, Bacillus anthracis, a Gram-positive spore-former, causes anthrax through a complex interplay between bacterial toxins and host responses. Beyond infection, the intestinal microbiota, which includes Gram-positive commensals, modulates the anticancer immune effects of cyclophosphamide, showing that responses to Gram-positive bacteria influence cancer therapy. At the molecular level, bacteria themselves respond to stress through competence regulons and quorum sensing, and these bacterial behaviors feed back into what the host senses. Researchers studying GO:0140459 therefore need robust experimental systems, including ex vivo cytokine assays and CRISPR-engineered cell models, to identify which host genes causally shape the response.
response to Gram-positive bacterium At A Glance
| GO ID | GO:0140459 |
|---|---|
| GO term | response to Gram-positive bacterium |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Cellular and organismal response to Gram-positive bacterial stimuli, including sensing of LTA and peptidoglycan and downstream immune activation |
| Key stimuli | Lipoteichoic acid (LTA), peptidoglycan, heat-killed Gram-positive bacteria |
| Key cell types | Macrophages, monocytes, and other innate immune cells |
| Related bacterial processes | Quorum sensing and competence regulons in Gram-positive bacteria |
| Disease relevance | Osteomyelitis, anthrax, microbiota-dependent anticancer immunity |
What Is GO:0140459?
In our own words, GO:0140459 response to Gram-positive bacterium refers to any process that results in a change in state or activity of a cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a Gram-positive bacterium. The term encompasses sensing of Gram-positive bacterial molecules such as lipoteichoic acid and peptidoglycan, downstream signal transduction, transcriptional reprogramming, and effector outputs such as cytokine secretion. It is a biological_process term and is distinct from responses to Gram-negative bacteria, although some signaling components are shared.
Why Is response to Gram-positive bacterium Important in Cell Biology?
GO:0140459 response to Gram-positive bacterium is important because Gram-positive pathogens are a leading cause of human infection, and the host response determines clinical outcome. Staphylococcus aureus osteomyelitis exemplifies how a Gram-positive bacterium can evade immunity and cause chronic bone destruction. Bacillus anthracis causes anthrax, a disease whose pathogenesis depends on host responses to a Gram-positive organism. The term is also important beyond infectious disease: the intestinal microbiota, rich in Gram-positive commensals, modulates the anticancer immune effects of cyclophosphamide, linking this response to cancer therapy. Finally, because the response is genetically tractable, it provides a model for discovering novel innate immune genes, as shown by forward genetic screens in macrophages.
• Gram-positive bacteria such as Staphylococcus aureus are major human pathogens, and the host response drives both protection and pathology.
• Lipoteichoic acid and peptidoglycan are conserved Gram-positive stimuli that activate innate immune signaling.
• Macrophage responses to Gram-positive bacteria are genetically regulated by specific innate immune genes.
• Bacterial quorum sensing and competence regulons shape the bacterial signals that the host detects.
• The response influences anticancer immunity through microbiota-host interactions.
• Anthrax pathogenesis depends on host responses to Bacillus anthracis, a Gram-positive pathogen.
• Ex vivo cytokine assays using LTA and heat-killed Gram-positive bacteria provide quantitative readouts.
• CRISPR screens can identify host genes that causally regulate this response.
• Understanding the response supports development of host-directed therapies for Gram-positive infections.
• The term connects microbiology, immunology, and cancer biology in a single annotation framework.
What Happens During response to Gram-positive bacterium?
Recognition of Gram-positive bacterial stimuli
In simple terms: The cell first detects molecules that are unique to Gram-positive bacteria.
The response begins when host cells encounter conserved Gram-positive bacterial molecules such as lipoteichoic acid (LTA) and peptidoglycan. These stimuli are used experimentally as purified LTA or as heat-killed Gram-positive bacteria to trigger the response in ex vivo assays. The magnitude of the response can be measured by cytokine production, for example interleukin-1 beta, and varies with host genotype.
Innate immune signal transduction
In simple terms: Detection triggers a signaling cascade inside the cell.
After sensing, intracellular signaling pathways are activated that lead to changes in gene expression and effector functions. Forward genetic approaches in macrophages have identified novel innate immune genes that regulate the response to Gram-positive bacteria, demonstrating that this step is genetically encoded and not merely a default inflammatory reaction.
Transcriptional and effector reprogramming
In simple terms: The cell changes which genes are turned on and what it secretes.
The response results in a change in state or activity of the cell, including altered gene expression and secretion of cytokines and other mediators. This reprogramming is the functional output that defines GO:0140459 and can be quantified by measuring cytokine release after stimulation with LTA or heat-killed Gram-positive bacteria.
Bacterial counter-regulation and stress responses
In simple terms: The bacteria themselves respond to stress, which changes what the host sees.
Gram-positive bacteria activate competence regulons as a general response to stress, and they coordinate behavior through quorum sensing. These bacterial processes alter the profile of molecules presented to the host and therefore shape the host response annotated by GO:0140459.
Integration with host physiology and disease
In simple terms: The response connects to whole-body outcomes like infection and cancer therapy.
The response to Gram-positive bacteria is not isolated to a single cell type; it integrates with host physiology. In osteomyelitis, the response to Staphylococcus aureus contributes to bone destruction and chronic infection. In cancer, the intestinal microbiota modulates the anticancer immune effects of cyclophosphamide, showing that responses to Gram-positive organisms can influence therapy outcomes.
Key Genes Involved in GO:0140459 response to Gram-positive bacterium
The following genes and proteins have been experimentally implicated in the response to Gram-positive bacteria or in the bacterial processes that generate the relevant stimuli.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL1B | Encodes interleukin-1 beta, a key cytokine produced in response to LTA and heat-killed Gram-positive bacteria | Readout in ex vivo stimulation assays |
| TLR2 | Senses lipoteichoic acid and other Gram-positive cell wall components | Core receptor for GO:0140459 |
| MYD88 | Adaptor protein downstream of TLR2 signaling | Central node in Gram-positive response |
| NFKB1 | Transcription factor driving inflammatory gene expression | Effector of transcriptional reprogramming |
| NLRP3 | Inflammasome component contributing to IL-1 beta maturation | Links sensing to cytokine output |
| CASP1 | Caspase-1 cleaves pro-IL-1 beta to active IL-1 beta | Effector of cytokine release |
| LY96 | MD-2 co-receptor for TLR2/TLR4 signaling | Modulates Gram-positive sensing |
| CD14 | Co-receptor that facilitates recognition of bacterial components | Enhances responsiveness to Gram-positive stimuli |
| TICAM1 | TRIF adaptor in TLR signaling | Contributes to inflammatory gene induction |
| TRAF6 | E3 ubiquitin ligase in TLR signaling | Signal transduction node |
| MAPK1 | Kinase in MAPK cascade activated by bacterial stimuli | Signal amplification |
| MAPK14 | p38 MAPK involved in inflammatory cytokine production | Stress response integration |
| RELA | NF-kappa-B subunit controlling inflammatory transcription | Transcriptional output |
| JUN | AP-1 component induced by bacterial stimuli | Transcriptional reprogramming |
| FOS | AP-1 component induced by bacterial stimuli | Transcriptional reprogramming |
| SAA1 | Acute-phase protein induced during infection | Systemic response marker |
| AGRP | Neuropeptide implicated in host response to Gram-positive bacteria | Novel innate immune gene candidate |
How Is response to Gram-positive bacterium Regulated?
The response to Gram-positive bacteria is regulated at multiple levels. Bacterial quorum sensing and competence regulons control the production of stimuli that the host detects, meaning the bacterial population itself regulates the intensity of the host response. On the host side, forward genetic screens have identified novel innate immune genes that positively or negatively regulate the macrophage response to Gram-positive bacteria, indicating that the response is under active genetic control rather than being a passive consequence of exposure. Cytokine output such as IL-1 beta is a regulated endpoint that integrates sensing, signaling and transcriptional events.
response to Gram-positive bacterium and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL1B | Inflammatory response to Gram-positive bacteria | Knockout and point-mutation in macrophages |
| TLR2 | Sensing of LTA and Gram-positive cell wall | Knockout in human cell lines |
| MYD88 | Signal transduction in Gram-positive response | Knockout and knock-in models |
| NLRP3 | Inflammasome-mediated cytokine release | Point-mutation and knockout |
| AGRP | Novel innate immune regulation | Overexpression and knockout |
Staphylococcus aureus osteomyelitis
Staphylococcus aureus is a Gram-positive pathogen and a leading cause of osteomyelitis. The host response to this organism contributes to bone destruction, abscess formation and chronic infection, making GO:0140459 directly relevant to musculoskeletal infectious disease.
Anthrax
Bacillus anthracis is a Gram-positive spore-forming bacterium that causes anthrax. Anthrax pathogenesis involves complex interactions between bacterial toxins and host responses, and the host response to this Gram-positive organism is a determinant of disease outcome.
Microbiota and anticancer immunity
The intestinal microbiota, which includes Gram-positive commensals, modulates the anticancer immune effects of cyclophosphamide. This demonstrates that responses to Gram-positive bacteria can influence cancer therapy efficacy, extending GO:0140459 beyond infectious disease.
Host genetic susceptibility to Gram-positive infection
Variation in host genes regulating the response to Gram-positive bacteria can alter susceptibility and severity of infection. Ex vivo assays using LTA and heat-killed Gram-positive bacteria reveal genotype-dependent differences in cytokine responses, supporting a role for host genetics in disease outcome.
From response to Gram-positive bacterium-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate cytokine response to LTA? | CRISPR knockout in macrophage-like cells followed by LTA stimulation |
| Does a specific variant alter Gram-positive sensing? | CRISPR point-mutation knock-in of the variant |
| Can a gene's expression be monitored during infection? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression enhance the response? | CRISPR overexpression or cDNA overexpression |
| Which genes are essential for the response? | Genome-wide CRISPR library screening |
| How does host genotype affect the response? | Ex vivo stimulation of primary cells from different genotypes |
How to Study the response to Gram-positive bacterium Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LTA stimulation assay | Cytokine production in response to Gram-positive stimulus | Quantifying GO:0140459 output |
| Heat-killed bacteria assay | Inflammatory response to whole Gram-positive bacteria | Comparing host genotypes |
| CRISPR knockout screen | Genes required for the response | Discovery of novel regulators |
| RNA-seq | Transcriptional changes after stimulation | Defining the response program |
| ELISA | Protein levels of cytokines such as IL-1 beta | Validating hits |
| Flow cytometry | Cell surface markers and viability | Characterizing responding cells |
| Quorum sensing reporter assay | Bacterial signaling activity | Linking bacterial behavior to host response |
| Competence induction assay | Bacterial stress response | Understanding stimulus production |
Ex vivo cytokine stimulation assays
Stimulation of cells with lipoteichoic acid (LTA) or heat-killed Gram-positive bacteria followed by measurement of cytokines such as IL-1 beta is a direct way to quantify the response. This approach has been used to show genotype-dependent differences in the response to Gram-positive stimuli.
Forward genetic screening
Forward genetic screens in macrophages can identify novel innate immune genes that regulate the response to Gram-positive bacteria. Such screens have revealed genes not previously known to participate in this response, providing unbiased discovery.
Transcriptional profiling
RNA sequencing after exposure to Gram-positive stimuli can define the transcriptional program of GO:0140459, including which inflammatory and effector genes are induced. This complements cytokine readouts by capturing the full change in cell state.
Bacterial genetics and quorum sensing assays
Because bacterial quorum sensing and competence regulons shape the stimuli presented to the host, studying these bacterial processes is necessary to interpret host responses. Assays for quorum sensing and competence induction provide the bacterial side of the interaction.
How CRISPR Can Be Used to Study GO:0140459 response to Gram-positive bacterium
Knockout
CRISPR knockout of candidate genes in macrophage-like cells followed by LTA or heat-killed Gram-positive bacterial stimulation can determine whether a gene is required for the response. This approach is directly supported by genetic evidence that specific innate immune genes regulate the macrophage response to Gram-positive bacteria.
Point Mutation
CRISPR point-mutation knock-in can be used to test whether specific variants in sensing or signaling genes alter the response to Gram-positive stimuli. This is valuable when a candidate variant is identified in human genetics studies of infection susceptibility.
Knock-in
Tagged knock-in of endogenous genes allows monitoring of protein localization and expression during the response to Gram-positive bacteria without overexpression artifacts. This can clarify which signaling components are recruited upon stimulation.
Overexpression
CRISPR overexpression or cDNA overexpression can test whether increasing the level of a candidate gene enhances or dampens the response to Gram-positive stimuli. This complements loss-of-function approaches and can reveal dose-sensitive regulators.
How EDITGENE Supports response to Gram-positive bacterium Research
Researchers studying response to Gram-positive bacterium-related genes often need to determine whether a candidate gene is causally involved in sensing, signaling or effector output. EDITGENE provides CRISPR-based cell model services that enable this causal testing in relevant human cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for response to Gram-positive bacterium research.
Frequently Asked Questions About response to Gram-positive bacterium
What is GO:0140459 response to Gram-positive bacterium?
GO:0140459 is a Gene Ontology biological process term describing any process that results in a change in state or activity of a cell or organism as a result of a stimulus from a Gram-positive bacterium.
What genes are involved in the response to Gram-positive bacteria?
Genes such as TLR2, MYD88, IL1B, NLRP3 and others have been implicated in sensing and responding to Gram-positive stimuli, and forward screens have identified additional innate immune genes.
What molecules from Gram-positive bacteria trigger the response?
Lipoteichoic acid (LTA) and peptidoglycan are conserved Gram-positive cell envelope molecules used experimentally to trigger the response.
How is the response to Gram-positive bacteria measured?
It is commonly measured by cytokine production, such as IL-1 beta, after stimulation with LTA or heat-killed Gram-positive bacteria.
Which cell types respond to Gram-positive bacteria?
Macrophages and other innate immune cells are central responders, and macrophage responses have been used to discover novel regulatory genes.
Is the response to Gram-positive bacteria different from Gram-negative?
The two responses share some signaling components but are distinct GO terms; Gram-positive stimuli such as LTA are recognized differently from Gram-negative lipopolysaccharide.
What diseases involve the response to Gram-positive bacteria?
Staphylococcus aureus osteomyelitis, anthrax, and microbiota-dependent anticancer immunity are examples where this response is relevant.
How do bacteria regulate the signals that trigger this response?
Gram-positive bacteria use quorum sensing and competence regulons, which are general stress responses that alter the molecules presented to the host.
Can CRISPR screens identify regulators of the response to Gram-positive bacteria?
Yes, forward genetic and CRISPR-based screens can identify genes that regulate the macrophage response to Gram-positive bacteria.
Why is host genetics important for the response to Gram-positive bacteria?
Ex vivo assays show genotype-dependent differences in cytokine responses to LTA and heat-killed Gram-positive bacteria, indicating host genetic control.
Conclusion
GO:0140459 response to Gram-positive bacterium is a biologically and clinically important process that spans sensing of conserved bacterial molecules, innate immune signaling, transcriptional reprogramming and effector output. It is relevant to infectious diseases such as Staphylococcus aureus osteomyelitis and anthrax, and to cancer therapy through microbiota-host interactions. CRISPR-based cell models and screening approaches provide powerful tools to dissect the causal genes and mechanisms underlying this response.
References
- 1. Miller MB et al.. 2001. Quorum sensing in bacteria.. Annu Rev Microbiol 55:165-99 PMID: 11544353
- 2. Urish KL et al.. 2020. Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery.. Infect Immun 88(7) PMID: 32094258
- 3. Moayeri M et al.. 2015. Anthrax Pathogenesis.. Annu Rev Microbiol 69:185-208 PMID: 26195305
- 4. Viaud S et al.. 2013. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.. Science 342(6161):971-6 PMID: 24264990
- 5. Brink AA et al.. 2023. Effect of Holstein genotype on ex-vivo interleukin-1β response to lipopolysaccharide (LPS), lipoteichoic acid (LTA) and heat-killed Gram-negative and Gram-positive bacteria.. Vet Immunol Immunopathol 258:110573 PMID: 36840993
- 6. Alper S et al.. 2016. Novel Innate Immune Genes Regulating the Macrophage Response to Gram Positive Bacteria.. Genetics 204(1):327-36 PMID: 27356610
- 8. Claverys JP et al.. 2006. Induction of competence regulons as a general response to stress in gram-positive bacteria.. Annu Rev Microbiol 60:451-75 PMID: 16771651
